Rafaèle Tordjman (Jeito)
November 13, 2020 06:23 AM ESTUpdated 06:58 AM
Financing

Dou­bling down on Sanofi's French roots, Paul Hud­son in­fus­es €50M in­to Jeito Cap­i­tal to boost home­grown biotechs

Amber Tong

Paul Hud­son head­ed in­to the Élysée Palace, sum­moned by French Pres­i­dent Em­man­u­al Macron, in deep trou­ble with the coun­try’s gov­ern­ing elites who were of­fend­ed by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times